{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:55:40Z","timestamp":1793850940925,"version":"4.6.1"},"reference-count":186,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a series of obesity-related metabolic liver diseases, ranging from relatively benign hepatic steatosis to metabolic-associated steatohepatitis (MASH). With the changes in lifestyle, its incidence and prevalence have risen to epidemic proportions globally. In recent years, an increasing amount of evidence has indicated that the hepatic microenvironment is involved in the pathophysiological processes of MASH-induced liver fibrosis and the formation of hepatocellular carcinoma (HCC). The hepatic microenvironment is composed of various parenchymal and non-parenchymal cells, which communicate with each other through various factors. In this review, we focus on the changes in hepatocytes, cholangiocytes, liver sinusoidal endothelial cells (LSECs), hepatic stellate cells (HSCs), Kupffer cells (KC), dendritic cells (DC), neutrophils, monocytes, T and B lymphocytes, natural killer cells (NK), natural killer T cells (NKT), mucosal-associated invariant T cells (MAIT), \u03b3\u03b4T cells, and gut microbiota during the progression of MASLD. Furthermore, we discuss promising therapeutic strategies targeting the microenvironment of MASLD-MASH-HCC.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1569915","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:12:06Z","timestamp":1745986326000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC"],"prefix":"10.3389","volume":"16","author":[{"given":"Qiulin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihe","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: A review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-065425","article-title":"Trends in body mass index, overweight and obesity among adults in the USA, the NHANES from 2003 to 2018: a repeat cross-sectional survey","volume":"12","author":"Li","year":"2022","journal-title":"BMJ Open"},{"key":"B4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: Pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.033","article-title":"Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation","volume":"79","author":"Yahoo","year":"2023","journal-title":"J Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"DAMPs and DAMP-sensing receptors in inflammation and diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30506","article-title":"The role of innate immune cells in nonalcoholic steatohepatitis","volume":"70","author":"Cai","year":"2019","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3390\/cancers15041308","article-title":"Non-parenchymal cells and the extracellular matrix in hepatocellular carcinoma in non-alcoholic fatty liver disease","volume":"15","author":"van Son","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2021.0157","article-title":"Inhibition of fatty acid translocase (FAT\/CD36) palmitoylation enhances hepatic fatty acid \u03b2-oxidation by increasing its localization to mitochondria and interaction with long-chain acyl-coA synthetase 1","volume":"36","author":"Zeng","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1025551","DOI":"10.3389\/fphar.2022.1025551","article-title":"BCATc inhibitor 2 ameliorated mitochondrial dysfunction and apoptosis in oleic acid-induced non-alcoholic fatty liver disease model","volume":"13","author":"Lu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2017.09.026","article-title":"AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species","volume":"21","author":"Rabinovitch","year":"2017","journal-title":"Cell Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i24.4330","article-title":"Implication of the Hedgehog pathway in hepatocellular carcinoma","volume":"23","author":"Della Corte","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202003721","article-title":"Adipocyte fatty acid binding protein promotes the onset and progression of liver fibrosis via mediating the crosstalk between liver sinusoidal endothelial cells and hepatic stellate cells","volume":"8","author":"Wu","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30150","article-title":"Ductular reaction in liver diseases: Pathological mechanisms and translational significances","volume":"69","author":"Sato","year":"2019","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"G102","DOI":"10.1152\/ajpgi.00452.2016","article-title":"Emerging concepts in biliary repair and fibrosis","volume":"313","author":"Fabris","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28622","article-title":"The secretin\/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-\u03b21 biliary secretion in mice","volume":"64","author":"Wu","year":"2016","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27840","article-title":"The biliary epithelium presents antigens to and activates natural killer T cells","volume":"62","author":"Schrumpf","year":"2015","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31871","article-title":"Inhibition of secretin\/secretin receptor axis ameliorates NAFLD phenotypes","volume":"74","author":"Chen","year":"2021","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.21965","article-title":"Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance","volume":"47","author":"Diehl","year":"2008","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159217","article-title":"Free fatty acids differentially downregulate chemokines in liver sinusoidal endothelial cells: Insights into non-alcoholic fatty liver disease","volume":"11","author":"McMahan","year":"2016","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.028","article-title":"A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis","volume":"72","author":"Hammoutene","year":"2020","journal-title":"J Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI73722","article-title":"Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis","volume":"125","author":"Weston","year":"2015","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.012","article-title":"Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease","volume":"70","author":"Hammoutene","year":"2019","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0255","article-title":"Endothelial NO\/cGMP\/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding","volume":"60","author":"Tateya","year":"2011","journal-title":"Diabetes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s00018-023-04966-7","article-title":"Liver endothelial cells in NAFLD and transition to NASH and HCC","volume":"80","author":"Velliou","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032785","article-title":"Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD","volume":"7","author":"Pasar\u00edn","year":"2012","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2016.09.002","article-title":"The hepatic lymphatic vascular system: Structure, function, markers, and lymphangiogenesis","volume":"2","author":"Tanaka","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"120355","DOI":"10.1016\/j.lfs.2022.120355","article-title":"Endothelial group IVA phospholipase A(2) promotes hepatic fibrosis with sinusoidal capillarization in the early stage of non-alcoholic steatohepatitis in mice","volume":"294","author":"Kawashita","year":"2022","journal-title":"Life Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115005","article-title":"Formation of fenestrae in murine liver sinusoids depends on plasmalemma vesicle-associated protein and is required for lipoprotein passage","volume":"9","author":"Herrnberger","year":"2014","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1530\/JME-14-0049","article-title":"oxLDL induces injury and defenestration of human liver sinusoidal endothelial cells via LOX1","volume":"53","author":"Zhang","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3109\/00313021003636469","article-title":"The effect of feeding and fasting on fenestrations in the liver sinusoidal endothelial cell","volume":"42","author":"O\u2019Reilly","year":"2010","journal-title":"Pathology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00949.2015","article-title":"Dietary macronutrients and the aging liver sinusoidal endothelial cell","volume":"310","author":"Cogger","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci Transl Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1038\/s41598-019-39112-6","article-title":"Transcriptional regulation of Hepatic Stellate Cell activation in NASH","volume":"9","author":"Marcher","year":"2019","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"G211","DOI":"10.1152\/ajpgi.00040.2019","article-title":"CD8(+) T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease","volume":"318","author":"Breuer","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","article-title":"Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation","volume":"73","author":"Bates","year":"2020","journal-title":"J Hepatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.7150\/thno.85369","article-title":"Secretome of senescent hepatic stellate cells favors Malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma","volume":"13","author":"Zhou","year":"2023","journal-title":"Theranostics"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatology"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062885","article-title":"Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis\u2013a longitudinal study","volume":"8","author":"Wong","year":"2013","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cmet.2019.08.002","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"30","author":"Loomba","year":"2019","journal-title":"Cell Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"B\u00e4ckhed","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2012.01.014","article-title":"Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model","volume":"24","author":"Wagnerberger","year":"2013","journal-title":"J Nutr Biochem"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat Commun"},{"key":"B62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J Hepatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","author":"Gadd","year":"2014","journal-title":"Hepatology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.immuni.2020.06.003","article-title":"Impaired kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis","volume":"53","author":"Tran","year":"2020","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.07.006","article-title":"CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis","volume":"61","author":"Zhang","year":"2014","journal-title":"J Hepatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","article-title":"Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism","volume":"1","author":"Lefere","year":"2019","journal-title":"JHEP Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"106220","DOI":"10.1016\/j.isci.2023.106220","article-title":"Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis","volume":"26","author":"Takimoto","year":"2023","journal-title":"iScience"},{"key":"B70","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fimmu.2019.00082","article-title":"The differential roles of T cells in non-alcoholic fatty liver disease and obesity","volume":"10","author":"Van Herck","year":"2019","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"44612","DOI":"10.1038\/srep44612","article-title":"Effect of modulation of PPAR-\u03b3 activity on Kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease","volume":"7","author":"Luo","year":"2017","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12964-024-01489-x","article-title":"MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwad062","article-title":"Galectin-12 modulates Kupffer cell polarization to alter the progression of nonalcoholic fatty liver disease","volume":"33","author":"Lee","year":"2023","journal-title":"Glycobiology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid-associated macrophages control metabolic homeostasis in a trem2-dependent manner","volume":"178","author":"Jaitin","year":"2019","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","first-page":"108626","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040124","article-title":"TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis","volume":"4","author":"Takahashi","year":"2007","journal-title":"PloS Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.004","article-title":"Soluble TREM2 levels reflect the recruitment and expansion of TREM2(+) macrophages that localize to fibrotic areas and limit NASH","volume":"77","author":"Hendrikx","year":"2022","journal-title":"J Hepatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.immuni.2022.11.013","article-title":"Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development","volume":"56","author":"Wang","year":"2023","journal-title":"Immunity"},{"key":"B81","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1186\/s12967-023-04716-0","article-title":"Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC)","volume":"21","author":"Huang","year":"2023","journal-title":"J Transl Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.08.024","article-title":"Combination of mass cytometry and imaging analysis reveals origin, location, and functional repopulation of liver myeloid cells in mice","volume":"151","author":"David","year":"2016","journal-title":"Gastroenterology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.06.003","article-title":"Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver","volume":"143","author":"Ibrahim","year":"2012","journal-title":"Gastroenterology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1042\/CS20150053","article-title":"CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis","volume":"129","author":"Sutti","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01344-3","article-title":"XCR1(+) type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis","volume":"27","author":"Deczkowska","year":"2021","journal-title":"Nat Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.01.008","article-title":"Murine CD103(+) dendritic cells protect against steatosis progression towards steatohepatitis","volume":"66","author":"Heier","year":"2017","journal-title":"J Hepatol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3389\/fimmu.2019.01255","article-title":"Retained NK cell phenotype and functionality in non-alcoholic fatty liver disease","volume":"10","author":"Stiglund","year":"2019","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/hep.26267","article-title":"Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice","volume":"58","author":"Henning","year":"2013","journal-title":"Hepatology"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41423-020-00560-0","article-title":"Neutrophils in liver diseases: Pathogenesis and therapeutic targets","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-010-0272-y","article-title":"Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet","volume":"45","author":"Miyagi","year":"2010","journal-title":"J Gastroenterol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s10020-019-0084-3","article-title":"Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes","volume":"25","author":"Mirea","year":"2019","journal-title":"Mol Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"van der Windt","year":"2018","journal-title":"Hepatology"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052411","article-title":"Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice","volume":"7","author":"Rensen","year":"2012","journal-title":"PloS One"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2885","article-title":"Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase","volume":"18","author":"Talukdar","year":"2012","journal-title":"Nat Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.08.111","article-title":"Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic ceramides metabolism","volume":"518","author":"Chen","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis","volume":"75","author":"Wang","year":"2021","journal-title":"J Hepatol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/liv.14307","article-title":"Hepatic NK cells attenuate fibrosis progression of non-alcoholic steatohepatitis in dependent of CXCL10-mediated recruitment","volume":"40","author":"Fan","year":"2020","journal-title":"Liver Int"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2016.01.020","article-title":"Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease","volume":"82","author":"Cepero-Donates","year":"2016","journal-title":"Cytokine"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2021.08.019","article-title":"Activated natural killer cell promotes nonalcoholic steatohepatitis through mediating JAK\/STAT pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/hep.23253","article-title":"Major histocompatibility complex class I-related chains A and B (MIC A\/B): a novel role in nonalcoholic steatohepatitis","volume":"51","author":"Kahraman","year":"2010","journal-title":"Hepatology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/cancers15030850","article-title":"Inhibition of checkpoint kinase 1 (CHK1) upregulates interferon regulatory factor 1 (IRF1) to promote apoptosis and activate anti-tumor immunity via MICA in hepatocellular carcinoma (HCC)","volume":"15","author":"Li","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301400","article-title":"NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis","volume":"61","author":"Gur","year":"2012","journal-title":"Gut"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230307","article-title":"Characterization of the immune cell landscape of patients with NAFLD","volume":"15","author":"Diedrich","year":"2020","journal-title":"PloS One"},{"key":"B105","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/hep.28389","article-title":"NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice","volume":"63","author":"Tosello-Trampont","year":"2016","journal-title":"Hepatology"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24798","article-title":"Attenuated liver fibrosis in the absence of B cells","volume":"115","author":"Novobrantseva","year":"2005","journal-title":"J Clin Invest"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2018.06.015","article-title":"B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)","volume":"124","author":"Bruzz\u00ec","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/cdd.2016.17.issue-7","article-title":"Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells","volume":"17","author":"Zhang","year":"2016","journal-title":"J Dig Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/s41598-018-37403-y","article-title":"Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease","volume":"9","author":"Nakamura","year":"2019","journal-title":"Sci Rep"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hep4.1041","article-title":"Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis","volume":"1","author":"Bhattacharjee","year":"2017","journal-title":"Hepatol Commun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1042\/CS20120289","article-title":"NF-\u03baB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses","volume":"124","author":"Locatelli","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"B114","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1038\/s41467-021-24734-0","article-title":"CD8(+) tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells","volume":"12","author":"Koda","year":"2021","journal-title":"Nat Commun"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90634.2008","article-title":"Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat","volume":"296","author":"Zigmond","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1096-9896","article-title":"Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob\/ob mice and is associated with intrahepatic CD8 trapping","volume":"209","author":"Elinav","year":"2006","journal-title":"J Pathol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canlet.2021.03.002","article-title":"Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10\/CXCR3 axis in hepatocellular carcinoma (HCC)","volume":"506","author":"Yan","year":"2021","journal-title":"Cancer Lett"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201802534RR","article-title":"The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32336","article-title":"T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis","volume":"75","author":"Ramadori","year":"2022","journal-title":"Hepatology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"967410","DOI":"10.3389\/fimmu.2022.967410","article-title":"CD4(+) T cell activation and inflammation in NASH-related fibrosis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20826","article-title":"Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease","volume":"42","author":"Li","year":"2005","journal-title":"Hepatology"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9571-1","article-title":"Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis","volume":"31","author":"Inzaugarat","year":"2011","journal-title":"J Clin Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9635-2","article-title":"The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis","volume":"32","author":"Ferreyra Solari","year":"2012","journal-title":"J Clin Immunol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jhep.2024.04.009","article-title":"Targeting EFHD2 inhibits interferon-\u03b3 signaling and ameliorates non-alcoholic steatohepatitis","volume":"81","author":"Fu","year":"2024","journal-title":"J Hepatol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1016\/j.celrep.2018.12.006","article-title":"OX40 regulates both innate and adaptive immunity and promotes nonalcoholic steatohepatitis","volume":"25","author":"Sun","year":"2018","journal-title":"Cell Rep"},{"key":"B127","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cellimm.2019.01.005","article-title":"Mesenteric lymph node CD4(+) T lymphocytes migrate to liver and contribute to non-alcoholic fatty liver disease","volume":"337","author":"Su","year":"2019","journal-title":"Cell Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of th17 cells in the liver and an increased th17\/resting regulatory T cell ratio in peripheral blood and in the liver","volume":"196","author":"Rau","year":"2016","journal-title":"J Immunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/CS20150405","article-title":"The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice","volume":"130","author":"Rolla","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4656","article-title":"Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model","volume":"181","author":"Shimamura","year":"2008","journal-title":"J Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26746","article-title":"IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice","volume":"59","author":"Harley","year":"2014","journal-title":"Hepatology"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2020.04.010","article-title":"Diet reversal and immune modulation show key role for liver and adipose tissue T cells in murine nonalcoholic steatohepatitis","volume":"10","author":"Van Herck","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fimmu.2014.00400","article-title":"Gamma delta T-lymphocytes in hepatitis C and chronic liver disease","volume":"5","author":"Rajoriya","year":"2014","journal-title":"Front Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cmet.2021.04.018","article-title":"PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease","volume":"33","author":"Moreno-Fernandez","year":"2021","journal-title":"Cell Metab"},{"key":"B135","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23291","article-title":"Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells","volume":"51","author":"Kuang","year":"2010","journal-title":"Hepatology"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma","volume":"30","author":"Gomes","year":"2016","journal-title":"Cancer Cell"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.03.004","article-title":"Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22","volume":"53","author":"Yang","year":"2010","journal-title":"J Hepatol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"648754","DOI":"10.3389\/fimmu.2021.648754","article-title":"Group 3 innate lymphoid cells protect steatohepatitis from high-fat diet induced toxicity","volume":"12","author":"Hamaguchi","year":"2021","journal-title":"Front Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1807","article-title":"The detrimental role of regulatory T cells in nonalcoholic steatohepatitis","volume":"6","author":"Dywicki","year":"2022","journal-title":"Hepatol Commun"},{"key":"B141","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cmet.2011.04.013","article-title":"Protection from obesity and diabetes by blockade of TGF-\u03b2\/Smad3 signaling","volume":"14","author":"Yadav","year":"2011","journal-title":"Cell Metab"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21823","article-title":"A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury","volume":"46","author":"Ma","year":"2007","journal-title":"Hepatology"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2018.07.011","article-title":"Toll-like receptor-7 signaling promotes nonalcoholic steatohepatitis by inhibiting regulatory T cells in mice","volume":"188","author":"Roh","year":"2018","journal-title":"Am J Pathol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3389\/fphys.2018.00640","article-title":"Obesity, fat mass and immune system: Role for leptin","volume":"9","author":"Francisco","year":"2018","journal-title":"Front Physiol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27233","article-title":"Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation","volume":"60","author":"Chatzigeorgiou","year":"2014","journal-title":"Hepatology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1038\/ncomms13839","article-title":"The microbiota maintain homeostasis of liver-resident \u03b3\u03b4T-17 cells in a lipid antigen\/CD1d-dependent manner","volume":"7","author":"Li","year":"2017","journal-title":"Nat Commun"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30952","article-title":"\u03b3\u03b4 T cells promote steatohepatitis by orchestrating innate and adaptive immune programming","volume":"71","author":"Torres-Hernandez","year":"2020","journal-title":"Hepatology"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203013","article-title":"IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation","volume":"191","author":"Tan","year":"2013","journal-title":"J Immunol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3389\/fimmu.2020.01500","article-title":"Roles of hepatic innate and innate-like lymphocytes in nonalcoholic steatohepatitis","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/hep.23599","article-title":"Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease","volume":"51","author":"Syn","year":"2010","journal-title":"Hepatology"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301857","article-title":"NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease","volume":"61","author":"Syn","year":"2012","journal-title":"Gut"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800614","article-title":"Differential activation of hepatic invariant NKT cell subsets plays a key role in progression of nonalcoholic steatohepatitis","volume":"201","author":"Maricic","year":"2018","journal-title":"J Immunol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"108116","DOI":"10.1016\/j.celrep.2020.108116","article-title":"High dimensional single-cell analysis reveals iNKT cell developmental trajectories and effector fate decision","volume":"32","author":"Baranek","year":"2020","journal-title":"Cell Rep"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23292","article-title":"Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis","volume":"51","author":"Kremer","year":"2010","journal-title":"Hepatology"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202814","article-title":"Tim-3\/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease","volume":"190","author":"Tang","year":"2013","journal-title":"J Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00872-3","article-title":"Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver","volume":"19","author":"Tang","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3389\/fimmu.2018.01994","article-title":"Mucosal-associated invariant T cells improve nonalcoholic fatty liver disease through regulating macrophage polarization","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1038\/s41467-018-04450-y","article-title":"Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver","volume":"9","author":"Hegde","year":"2018","journal-title":"Nat Commun"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3854","article-title":"Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes","volume":"18","author":"Rouxel","year":"2017","journal-title":"Nat Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13659","article-title":"Is there an \u2018ideal\u2019 diet for patients with NAFLD","volume":"52","author":"Pugliese","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"B161","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s42255-019-0093-0","article-title":"Author Correction: Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution","volume":"1","author":"Haas","year":"2019","journal-title":"Nat Metab"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat Med"},{"key":"B164","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"B165","doi-asserted-by":"publisher","first-page":"60","DOI":"10.17925\/EE.2023.19.1.60","article-title":"Resmetirom: an orally administered, smallmolecule, liver-directed, \u03b2-selective THR agonist for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"19","author":"Karim","year":"2023","journal-title":"touchREV Endocrinol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213714","article-title":"Cell-specific transport and thyroid hormone receptor isoform selectivity account for hepatocyte-targeted thyromimetic action of MGL-3196","volume":"23","author":"H\u00f6nes","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15427","article-title":"Activation of thyroid hormone receptor-\u03b2 improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis","volume":"178","author":"Kannt","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1177\/10600280241259528","article-title":"Resmetirom: the first food and drug administration-approved medication for nonalcoholic steatohepatitis (NASH)","volume":"59","author":"Guirguis","year":"2025","journal-title":"Ann Pharmacother"},{"key":"B169","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s41669-022-00370-2","article-title":"Early cost-effectiveness and price threshold analyses of resmetirom: an investigational treatment for management of nonalcoholic steatohepatitis","volume":"7","author":"Javanbakht","year":"2023","journal-title":"Pharmacoecon Open"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: First approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"key":"B171","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/hep.31108","article-title":"Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: Final analysis of the phase 2b CENTAUR study","volume":"72","author":"Ratziu","year":"2020","journal-title":"Hepatology"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2019.105889","article-title":"A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial","volume":"88","author":"Pedrosa","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol Rev"},{"key":"B174","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10875-015-0160-6","article-title":"Oral administration of OKT3 MAb to patients with NASH, promotes regulatory T-cell induction, and alleviates insulin resistance: Results of a phase IIa blinded placebo-controlled trial","volume":"35","author":"Lalazar","year":"2015","journal-title":"J Clin Immunol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13159","article-title":"Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH","volume":"193","author":"Ilan","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.030","article-title":"Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice","volume":"73","author":"Du","year":"2020","journal-title":"J Hepatol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/j.gastro.2019.05.002","article-title":"Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis","volume":"157","author":"Widjaja","year":"2019","journal-title":"Gastroenterology"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.732743","article-title":"Targeting liver fibrosis with a cell-penetrating protease-activated receptor-2 (PAR2) pepducin","volume":"291","author":"Shearer","year":"2016","journal-title":"J Biol Chem"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrac167","article-title":"Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: Meta-analysis","volume":"7","author":"Su","year":"2023","journal-title":"BJS Open"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2021.01.009","article-title":"Outcomes after curative therapy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a meta-analysis and review of current literature","volume":"23","author":"Chin","year":"2021","journal-title":"HPB (Oxford)"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15129","article-title":"Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease","volume":"42","author":"Nguyen","year":"2022","journal-title":"Liver Int"},{"key":"B182","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00270-019-02363-x","article-title":"Transarterial chemoembolization of hepatocellular carcinoma: Propensity score matching study comparing survival and complications in patients with nonalcoholic steatohepatitis versus other causes cirrhosis","volume":"43","author":"Young","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.06.008","article-title":"Evidence-based management of hepatocellular carcinoma: Systematic review and meta-analysis of randomized controlled trials (2002-2020)","volume":"161","author":"Haber","year":"2021","journal-title":"Gastroenterology"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4367","article-title":"First-line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study","volume":"10","author":"Shimose","year":"2021","journal-title":"Cancer Med"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100330","article-title":"Nonalcoholic steatohepatitis in hepatocarcinoma: New insights about its prognostic role in patients treated with lenvatinib","volume":"6","author":"Rimini","year":"2021","journal-title":"ESMO Open"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1569915\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:12:07Z","timestamp":1745986327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1569915\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":186,"alternative-id":["10.3389\/fimmu.2025.1569915"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1569915","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"article-number":"1569915"}}